Eledon Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Eledon Pharmaceuticals (ELDN).

Price Target Range — 8 Quarters

Analyst Consensus — 4 Analysts

4Buy

Consensus RatingBuy# Analysts4Avg. Consensus PT$11Upside to Avg. PT+394.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 21, 2026	Rodman & Renshaw	Seema Sheoran	Initiate	Buy	$12
Nov 18, 2025	Guggenheim	Vamil Divan	PT Cut	Buy	$9→$8
Sep 2, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$9
Jul 25, 2025	Craig-Hallum	—	Initiate	Buy	$12
Jun 18, 2025	HC Wainwright & Co.	Yi Chen	Assumes	Buy	$9
Nov 20, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$16
Jun 4, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$16
May 10, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$16
May 7, 2024	HC Wainwright & Co.	Vernon Bernardino	PT Raise	Buy	$13→$16
Mar 22, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$13
Nov 13, 2023	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$13
Oct 24, 2023	HC Wainwright & Co.	Vernon Bernardino	PT Cut	Buy	$25→$13

More with Benzinga EdgeGet Access

Analyst Ratings News

This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday

Wall Street analysts upgraded Fortinet, Goldman Sachs, Adaptive Biotechnologies, and Five Below, with positive outlooks and raised price targets.

Avi Kapoor

This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts change outlook on top stocks. For analyst rating changes, see https://www.benzinga.com/analyst-stock-ratings. INSM initiated with $192 PT.

Avi Kapoor

PRO
Rodman & Renshaw Initiates Coverage On Eledon Pharmaceuticals with Buy Rating, Announces Price Target of $12

Rodman & Renshaw analyst Seema Sheoran initiates coverage on Eledon Pharmaceuticals (NASDAQ:ELDN) with a Buy rating and announces Price Target of $12.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Eledon Pharmaceuticals, Lowers Price Target to $8

Guggenheim analyst Vamil Divan maintains Eledon Pharmaceuticals (NASDAQ:ELDN) with a Buy and lowers the price target from $9 to $8.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Eledon Pharmaceuticals, Maintains $9 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Eledon Pharmaceuticals (NASDAQ:ELDN) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
Craig-Hallum Initiates Coverage On Eledon Pharmaceuticals with Buy Rating, Announces Price Target of $12

Craig-Hallum initiates coverage on Eledon Pharmaceuticals (NASDAQ:ELDN) with a Buy rating and announces Price Target of $12.

Benzinga Newsdesk

Eledon Pharmaceuticals Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Eledon Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday

This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

PRO
Rodman & Renshaw Initiates Coverage On Eledon Pharmaceuticals with Buy Rating, Announces Price Target of $12

PRO
Guggenheim Maintains Buy on Eledon Pharmaceuticals, Lowers Price Target to $8

PRO
HC Wainwright & Co. Reiterates Buy on Eledon Pharmaceuticals, Maintains $9 Price Target

PRO
Craig-Hallum Initiates Coverage On Eledon Pharmaceuticals with Buy Rating, Announces Price Target of $12

People Also Watch

People Also Watch

Eledon Pharmaceuticals Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Eledon Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Fortinet Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday

This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

PRORodman & Renshaw Initiates Coverage On Eledon Pharmaceuticals with Buy Rating, Announces Price Target of $12

PROGuggenheim Maintains Buy on Eledon Pharmaceuticals, Lowers Price Target to $8

PROHC Wainwright & Co. Reiterates Buy on Eledon Pharmaceuticals, Maintains $9 Price Target

PROCraig-Hallum Initiates Coverage On Eledon Pharmaceuticals with Buy Rating, Announces Price Target of $12

People Also Watch

People Also Watch

PRO
Rodman & Renshaw Initiates Coverage On Eledon Pharmaceuticals with Buy Rating, Announces Price Target of $12

PRO
Guggenheim Maintains Buy on Eledon Pharmaceuticals, Lowers Price Target to $8

PRO
HC Wainwright & Co. Reiterates Buy on Eledon Pharmaceuticals, Maintains $9 Price Target

PRO
Craig-Hallum Initiates Coverage On Eledon Pharmaceuticals with Buy Rating, Announces Price Target of $12